Procedure-to-delivery interval after late amniocentesis and the need for routine antenatal corticosteroids.


Journal

The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians
ISSN: 1476-4954
Titre abrégé: J Matern Fetal Neonatal Med
Pays: England
ID NLM: 101136916

Informations de publication

Date de publication:
Nov 2022
Historique:
pubmed: 24 11 2020
medline: 2 9 2022
entrez: 23 11 2020
Statut: ppublish

Résumé

The aim of this study is to assess the procedure-to-delivery interval (PDI), the obstetric complications, and the early neonatal outcome in patients that did or did not receive glucocorticosteroids (GCSs) before third-trimester amniocentesis (TTA). A retrospectively analysis of 445 TTA procedures divided into two groups based on the administration (study group = 220 patients) or not (control group = 225 patients) of GCSs before TTA. The PDI was calculated for all patients. Obstetric and neonatal outcomes were compared between the groups. The rate of procedure-associated complications was similar between the groups. The mean PDI was 47.2 ± 16.8 days. The overall incidence of preterm birth was 11.7%; 9% delivered between 34 and 37 weeks and 2.7% between 28 and 34 weeks. Only nine patients (2%) delivered within seven days following TTA. The incidence of respiratory distress syndrome in the study and control groups was 1.8% and 1.3%, In the present study, the administration of glucocorticoids prior to TTA did not reduce the rates of neonatal complications, which was similar in both groups and not higher than the general population.

Identifiants

pubmed: 33225769
doi: 10.1080/14767058.2020.1849115
doi:

Substances chimiques

Adrenal Cortex Hormones 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

4338-4345

Auteurs

Sophia Leytes (S)

Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.
Department of Obstetrics and Gynecology, Edith Wolfson Medical Center, Holon, Israel.

Karina Krajden Haratz (KK)

Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.
Department of Obstetrics and Gynecology, Division of Ultrasound in ObGyn, Lis Maternity Hospital, Tel Aviv Medical Center, Tel Aviv, Israel.

Leonti Grin (L)

Department of Obstetrics and Gynecology, Faculty of Health Sciences, Barzilai University Medical Center, Ben-Gurion University of the Negev, Beersheba, Israel.

Tomer Shwartz (T)

Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.

Efraim Zohav (E)

Department of Obstetrics and Gynecology, Faculty of Health Sciences, Barzilai University Medical Center, Ben-Gurion University of the Negev, Beersheba, Israel.

Boaz Weisz (B)

Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.
Ultrasound in Obstetrics and Gynecology Unit, Chaim Sheba Medical Center, Ramat Gan, Israel.

Shlomo Lipitz (S)

Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.
Ultrasound in Obstetrics and Gynecology Unit, Chaim Sheba Medical Center, Ramat Gan, Israel.

Ron Maymon (R)

Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.
Department of Obstetrics and Gynecology, Shamir Medical Center (Assaf Harofeh), Be'er Ya'akov, Israel.

Ron Bardin (R)

Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.
Helen Schneider Women's Hospital, Rabin Medical Center, Petah Tikva, Israel.

Yinon Gilboa (Y)

Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.
Helen Schneider Women's Hospital, Rabin Medical Center, Petah Tikva, Israel.

Ilia Kleiner (I)

Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.
Department of Obstetrics and Gynecology, Edith Wolfson Medical Center, Holon, Israel.

Alon Kashanian (A)

Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.

Dorit Lev (D)

Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.
Department of Obstetrics and Gynecology, Edith Wolfson Medical Center, Holon, Israel.

Jacob Bar (J)

Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.
Department of Obstetrics and Gynecology, Edith Wolfson Medical Center, Holon, Israel.

Josef Shalev (J)

Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.
Department of Obstetrics and Gynecology, Edith Wolfson Medical Center, Holon, Israel.

Liat Gindes (L)

Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.
Department of Obstetrics and Gynecology, Edith Wolfson Medical Center, Holon, Israel.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH